최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국콘텐츠학회논문지 = The Journal of the Korea Contents Association, v.21 no.2, 2021년, pp.248 - 261
노현선 (동방문화대학원대학교 뷰티예술학과) , 김문주 (동방문화대학원대학교 뷰티예술학과)
The purpose of this study is that the blood nutrient indicator in adult women, is the depressive indicator. This study recruited 77 pre-menopausal women, and excluding missing values, 53 (mean age 44.2±6.5 years) blood indexes were statistically confirmed and then analyzed the effect of indexes...
S. Vivekanantham, R. Strawbridge, R. Rampuri, T. Ragunathan, and A. H. Young "Parity of publication for psychiatry," The British Journal of Psychiatry, Vol.209, No.3, pp.257-261, 2016.
M. Fava, "Diagnosis and definition of treatment-resistant depression," Biological psychiatry, Vol.53, No.8, pp.649-659, 2003.
S. Kapur, A. G. Phillips, and T. R. Insel, "Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?," Molecular psychiatry, Vol.17, No.12, pp.1174-1179, 2012.
A. Fekadu, L. J. Rane, S. C. Wooderson, K. Markopoulou, L. Poon, and A. J. Cleare, "Prediction of longer-term outcome of treatment-resistant depression in tertiary care," The British Journal of Psychiatry, Vol.201, No.5, pp.369-375, 2012.
A. Fekadu, S. C. Wooderson, K. Markopoulo, C. Donaldson, A. Papadopoulos, and A. J. Cleare, "What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies," Journal of affective disorders, Vol.116, No.1-2, pp.4-11, 2009.
D. Bennabi, B. Aouizerate, W. El-Hage, O. Doumy, F. Moliere, P. Courtet, and G. Vaiva, "Risk factors for treatment resistance in unipolar depression: a systematic review," Journal of affective disorders, Vol.171, pp.137-141, 2015.
A. A. Nierenberg, "Predictors of response to antidepressants: General principles and clinical implications," Psychiatric Clinics of North America, Vol.26, No.2, pp.345-352, 2003.
M. E. Thase, "Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies," Dialogues in clinical neuroscience, Vol.16, No.4, p.539, 2014.
M. R. Irwin and A. H. Miller, "Depressive disorders and immunity: 20 years of progress and discovery," Brain, behavior, and immunity, Vol.21, No.4, pp.374-383, 2007.
L. Bocchio-Chiavetto, V. Bagnardi, R. Zanardini, R. Molteni, M. Gabriela Nielsen, A. Placentino, and M. A. Riva, "Serum and plasma BDNF levels in major depression: a replication study and meta-analyses," The World Journal of Biological Psychiatry, Vol.11, No.6, pp.763-773, 2010.
J. P. Jacobsen, A. D. Krystal, K. R. Krishnan, and M. G. Caron, "Adjunctive 5-Hydroxytryptophan slow-release for treatment-resistant depression: clinical and preclinical rationale," Trends in pharmacological sciences, Vol.37, No.11, pp.933-944, 2016.
F. Ali and C. B. Nemeroff, "Neuroendocrine Alterations in Major Depressive Disorder," in Major Depressive Disorder, Elsevier, pp.63-74, 2020.
A. Dregan, L. Rayner, K. A. Davis, I. Bakolis, J. A. de la Torre, J. Das-Munshi, and M. Hotopf, "Associations between depression, arterial stiffness, and metabolic syndrome among adults in the UK Biobank Population Study: a mediation analysis," JAMA psychiatry, Vol.77, No.6, pp.598-606, 2020.
F. T. Endomba, A. T. Tankeu, J.R. Nkeck, and J. N. Tochie, "Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?," Lipids in Health and Disease, Vol.19, No.1, pp.1-12, 2020.
C. Li, F. Meng, J. C. Garza, J. Liu, Y. Lei, S. A. kirov, and X. Y. Lu, "Modulation of depression-related behaviors by adiponectin AdipoR1 receptors in 5-HT neurons," Molecular Psychiatry, pp.1-16, 2020.
L. A. Stone, E. S. Harmatz, and K. A. Goosens, "Ghrelin as a Stress Hormone: Implications for Psychiatric Illness," Biological Psychiatry, Vol.88, No.7, pp.531-540, 2020.
Y. G. Wei, D. B. Cai, R. X. Liu, J. Liu, S. B. Wang, Y. Q. Tang, and F. Wang, "Cholesterol and triglyceride levels in first-episode patients with major depressive disorder: A meta-analysis of case-control studies," Journal of Affective Disorders, Vol.266, pp.465-472, 2020.
R. Colle, P. Masson, C. Verstuyft, B. Feve, E. Werner, C. Boursier-Neyret, and B. Falissard, "Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study," Psychiatry and Clinical Neurosciences, Vol.74, No.2, pp.112-117, 2020.
C. Nasca, J. Dobbin, B. Bigio, K. Watson, P. de Angelis, M. Kautz, and F. S. Lee, "Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance," Molecular Psychiatry, pp.1-10, 2020.
M. Daujat-Chavanieu and M. Kot, "Albumin is a secret factor involved in multidirectional interactions among the serotoninergic, immune and endocrine systems that supervises the mechanism of CYP1A and CYP3A regulation in the liver," Pharmacology & Therapeutics, Vol.215, p.107616, 2020.
S. Moussavi, S. Chatterji, E. Verdes, A. tandon, V. Patel, and B. Ustun, "Depression, chronic diseases, and decrements in health: results from the World Health Surveys," The Lancet, Vol.370, No.9590, pp.851-858, 2007.
L. Gossec, J. Walsh, K. Michaud, E. holdsworth, S. Peterson, S. Meakin, and A. Ogdie, AB0821 ANXIETY AND DEPRESSION IN PSORIATIC ARTHRITIS (PsA)-PREVALENCE AND IMPACT ON PATIENT REPORTED OUTCOMES: REAL-WORLD SURVEY IN THE US AND EUROPE, BMJ Publishing Group Ltd., 2020.
J. M. Woo, W. Kim, T. Y. Hwang, K. D. Frick, B. H. Chio, Y. J. Seo, and J. S. Lee, "Impact of depression on work productivity and its improvement after outpatient treatment with antidepressants," Value in Health, Vol.14, No.4, pp.475-482, 2011.
G. W. Blair-West, C. H. Cantor, G. W. Mellsop, and M. L. Eyeson-Annan, "Lifetime suicide risk in major depression: sex and age determinants," Journal of affective disorders, Vol.55, No.2-3, pp.171-178, 1999.
P. Alboni, E. Favaron, N. Paparella, M. Sciammarella, and M. Pedaci, "Is there an association between depression and cardiovascular mortality or sudden death?," Journal of Cardiovascular Medicine, Vol.9, No.4, pp.356-362, 2008.
T. Partonen, J. Haukka, J. Virtamo, P. Taylor, and J. Lonnqvist, "Association of low serum total cholesterol with major depression and suicide," The British Journal of Psychiatry, Vol.175, No.3, pp.259-262, 1999.
I. Bjorkhem and S. Meaney, "Brain cholesterol: long secret life behind a barrier," Arteriosclerosis, thrombosis, and vascular biology, Vol.24, No.5, pp.806-815, 2004.
G. Saher, B. Brugger, C. Lappe-Siefke, W. Mobius, R-r. Tozawa, M. C. Wehr, and K. A. Nave, "High cholesterol level is essential for myelin membrane growth," Nature neuroscience, Vol.8, No.4, pp.468-475, 2005.
C. Goritz, D. H. Mauch, and F. W. Pfrieger, "Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron," Molecular and Cellular Neuroscience, Vol.29, No.2, pp.190-201, 2005.
K. H. Pfenninger, "Plasma membrane expansion: a neuron's Herculean task," Nature Reviews Neuroscience, Vol.10, No.4, pp.251-261, 2009.
S. Takamori, M. Holt, K. Stenius, E. A. Lemke, M. Gronborg, D. Riedel, and P. Ringler, "Molecular anatomy of a trafficking organelle," Cell, Vol.127, No.4, pp.831-846, 2006.
J. M. Dietschy and S. D. Turley, "Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal," Journal of lipid research, Vol.45, No.8, pp.1375-1397, 2004.
J. Zhang and Q. Liu, "Cholesterol metabolism and homeostasis in the brain," Protein & cell, Vol.6, No.4, pp.254-264, 2015.
P. A. Alphonse and P. J. Jones, "Revisiting human cholesterol synthesis and absorption: the reciprocity paradigm and its key regulators," Lipids, Vol.51, No.5, pp.519-536, 2016.
A. A. Ariyo, M. Haan, C. M. tangen, J. C. Rutledge, M. Cushman, A. Dobs, and C. D. Furberg, "Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans," Circulation, Vol.102, No.15, pp.1773-1779, 2000.
B. W. Penninx, A. T. Beekman, A. Honig, D. J. Deeg, R. A. Schoevers, J. T. van Eijk, and W. Van Tilburg, "Depression and cardiac mortality: results from a community-based longitudinal study," Archives of general psychiatry, Vol.58, No.3, pp.221-227, 2001.
W. Jiang, J. Alexander, E. Christopher, M. Kuchibhatla, L. H. Gaulden, M. S. Cuffe, and R. R. Krishnan, "Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure," Archives of internal medicine, Vol.161, No.15, pp.1849-1856, 2001.
E. J. Martens, P. W. Hoen, M. Mittelheauser, P. de Jonge, and J. Denollet, "Symptom dimensions of post-myocardial infarction depression, disease severity and cardiac prognosis." Psychol Med, Vol.40, No.5, pp.807-814, 2010.
J. I. Travella, A. W. Forrester, S. K. Schultz, and R. G. Robinson, "Depression following myocardial infarction: a one year longitudinal study," The International Journal of Psychiatry in Medicine, Vol.24, No.4, pp.357-369, 1994.
A. Trpkovic, I. Resanovic, J. Stanimirovic, D. Radak, S. A. mousa, D. Cenic-Milosevic, and E. R. lsenovic, "Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases," Critical reviews in clinical laboratory sciences, Vol.52, No.2, pp.70-85, 2015.
P. Barter, "The role of HDL-cholesterol in preventing atherosclerotic disease," European heart journal Supplements, Vol.7, suppl.F, pp.F4-F8, 2005.
J. M. Zich, C. C. Attkisson, and T. K. Greenfield, "Screening for depression in primary care clinics: the CES-D and the BDI," The International Journal of Psychiatry in Medicine, Vol.20, No.3, pp.259-277, 1990.
S. Mora, M. Szklo, J. D. Otvos, P. Greenland, B. M. Psaty, D. C. Goff Jr, and A. R. Hsarrett, "LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)," Atherosclerosis, Vol.192, No.1, pp.211-217, 2007.
T. Terao, N. lwata, K. Kanazawa, T. Takano, N. Takahashi, T. Hayashi, and Y. Sugawara, "Low serum cholesterol levels and depressive state in human dock visitors," Acta Psychiatrica Scandinavica, Vol.101, No.3, pp.231-234, 2000.
M. Horsten, S. P. Wamala, A. Vingerhoets, and K. Orth-Gomer, "Depressive symptoms, social support, and lipid profile in healthy middle-aged women," Psychosomatic medicine, Vol.59, No.5, pp.521-528, 1997.
J. Rabe-Jablonska and I. Poprawska, "Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission," Med Sci Monit, Vol.6, No.3, pp.539-547, 2000.
S. O. Olusi and A. A. Fido, "Serum lipid concentrations in patients with major depressive disorder," Biological Psychiatry, Vol.40, No.11, pp.1128-1131, 1996.
A. Gupta, S. Petker, A. Jadhav, and V. Dubey, "Study of lipid derangement in pyschiatric disorder," Ind Med Gazt, Vol.147. No.7, pp.253-256, 2013.
S. K. W. Avram, H. J. Lee, J. Fastman, A. Cymerblit-Sabba, M. Vincent, and N. I. Cilz, "NMDA receptor in vasopressin 1b neurons is not required for short-term social memory, object memory or aggression," Frontiers in Behavioral Neuroscience, Vol.13, pp.1-20, 2019.
K. Nishimura,Yoshino, K. Sanada, H. Beppu, Y. Akiyama, H. Nishimura, and M. Yoshimura, "Effect of oestrogen-dependent vasopressin on HPA axis in the median eminence of female rats," Scientific reports, Vol.9, No.1, pp.1-9, 2019.
A. Agorastos, A. Sommer, A. Heinig, K. Wiedemann, and C. Demiralay, "Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study," Frontiers in Psychiatry, Vol.11, p.453, 2020.
M. F. Lokhandwala, "Role of kidney dopamine in sodium excretion," Peripheral dopamine pathophysiology, pp.79-86, 2019.
I. H. Franken, I. Nijs, and L. Pepplinkhuizen, "Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli." Psychopharmacology (Berl), Vol.195, No.4, pp.537-546, 2008.
A. Alcaro, R. Huber, and J. Panksepp, "Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective," Brain research reviews, Vol.56, No.2, pp.283-321, 2007.
A. Zauner, W. P. Daugherty, M. R. Bullock, and D. S. Warner, "Brain oxygenation and energy metabolism: part I-biological function and pathophysiology," Neurosurgery, Vol.51, No.2, pp.289-301, discussion 302, 2002.
S. Major, G. C. Petzold, C. Reiffurth, O. Windmuller, M. Foddis, U. Lindauer, and J. P. Dreier, "A role of the sodium pump in spreading ischemia in rate," Journal of Cerebral Blood Flow & Metabolism, Vol.37, No.5, pp.1687-1705, 2017.
Y. Ben-Ari, "NKCC1 Chloride Importer Antagonists Attenuate Many Neurological and Psychiatric Disorders," Trends Neurosci, Vol.40, No.9, pp.536-554, 2017.
E. Delpire and K. J. Staley, "Novel determinants of the neuronal Cl(-) concentration," The Journal of physiology, Vol.592, No.19, pp.4099-4114, 2014.
I. Chamma, Q. Chevy, J. C. Poncer, and S. Levi, "Role of the neuronal K-Cl co-transporter KCC2 in inhibitory and excitatory neurotransmission," Frontiers in cellular neuroscience, Vol.6, p.5, 2012.
J. T. Schulte, C. J. Wierenga, and H. Bruining, "Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions," Neurosci Biobehav Rev, Vol.90, pp.260-271, 2018.
F. Ali and C. B. Nemeroff, Neuroendocrine Alterations in Major Depressive Disorder, in Major Depressive Disorder, Elsevier, pp.63-74, 2020.
O. Altindag, A. Altindag, M.Asoglu, M. Gunes, N. Soran, and Z. Deveci, "Relation of cortisol levels and bone mineral density among premenopausal women with major depression," International Journal of Clinical Practice, Vol.61, No.3, pp.416-420, 2007.
E. S. Lee,1, Y. H. Kim, S. H. Beck, S. Y. Lee, and S. W. Oh, "Depressive mood and abdominal fat distribution in overweight premenopausal women," Obesity Research, Vol.13, No.2, pp.320-325, 2005.
A. T. Beck, R. A. Steer, and G. K. Brown, Beck depression inventory (BDI-II), Pearson, 1996.
M. Brown, C. Kaplan, and L. Jason, "Factor analysis of the Beck Depression Inventory-II with patients with chronic fatigue syndrome," Journal of health psychology, Vol.17, pp.799-808, 2011.
F. J. Gennari, "Disorders of potassium homeostasis: hypokalemia and hyperkalemia," Critical care clinics, Vol.18, No.2, pp.273-288, 2002.
J. Volpi-Abadie, A. M. Kaye, and A. D. Kaye, "Serotonin syndrome," The Ochsner journal, Vol.13, No.4, pp.533-540, 2013.
S. Mrug, C. Orihuela, M. Mrug, and P. W. Sanders, "Sodium and potassium excretion predict increased depression in urban adolescents," Physiological reports, Vol.7, No.16, pp.e14213-e14213, 2019.
M. Muller, "Effects of chloride transport inhibition and chloride substitution on neuron function and on hypoxic spreading-depression-like depolarization in rat hippocampal slices," Neuroscience, Vol.97, No.1, pp.33-45, 2000.
A. Agorastos, A. Sommer, A. Heinig, K. Wiedemann, and C. Demirala, "Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study," Frontiers in Psychiatry, Vol.11, p.453, 2020.
S. J. Torres and C. A. Nowson, "A moderate-sodium DASH-type diet improves mood in postmenopausal women," Nutrition, Vol.28, No.9, pp.896-900, 2012.
M. Szkup, A. Jurczak, A. Brodowska, L. Niocen, D. Chlubek, and E. Grochans, "Analysis of relations between the level of Mg, Zn, Ca, Cu, and Fe and depressiveness in postmenopausal women," Biological trace element research, Vol.176, No.1, pp.56-63, 2017.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.